Abstract
Labeling of delafloxacin with technetium-99m (99mTc) and its characterization in terms of in vitro stability and in vitro binding with methicillin-resistant Staphylococcus aureus (MRSA) were explored. Optimum amounts of reactants were 2.5 mg delafloxacin, 125 µg stannous chloride dihydrate and ~125 MBq pertechnetate. The 99mTc-delafloxacin was stable up to 6 h. Molecular modeling and docking studies showed that the complex will stabilize the DNA-topoisomerase IIA cleavage complex and inhibit strands separation. The in vivo evaluation showed highest specific accumulation in the live MRSA model (8 %) compared to other models. All gathered data supported the usefulness of 99mTc-delafloxacin as a MRSA radiotracer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
